Stay informed about the latest NephCure's RKD clinical trials, research advancements, and how you can participate in groundbreaking studies.
clinical trialpharmacologyHiddo J.L. HeerspinkDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsMatthias KretzlerDepartment of Medicine-Nephrology and Computational Medicine and Bioinformatics University of Michigan, Ann Arbor...
Advanced kidney cancer (RCC) View all clinical trials KEYTRUDA+ axitinib helped patientslive longercompared to sunitinib A clinical trial compared patients with advanced renal cell carcinoma who received KEYTRUDA, an immunotherapy, in combination with axitinib, a tyrosine kinase inhibitor (TKI), to thos...
Researchers from UNSW and The George Institute for Global Health collaborated with researchers from the Australasian Kidney Trials Network to conduct a two-year trial – the CKD-FIX Study – across 31 hospitals in Australia and New Zealand. They enrolled 369 patients with chronic ...
Acute kidney injury (AKI) is a common clinical condition with various causes and is associated with increased mortality. Despite advances in supportive care, AKI increases not only the risk of premature death compared with the general population but also
Polycystic Kidney Disease Clinical Trials Network: DK‐01‐029doi:10.2310/6650.2001.33805Journal of Investigative Medicine
While cardiovascular outcome trials of SGLT-2i show a positive effect of SGLT-2i on several kidney disease-related endpoints, the effect of GLP-1 RA on kidney-disease endpoints other than reduced albuminuria remain to be established. Non-steroidal mineralocorticoid receptor antagonists also evoke ...
Find out more about advanced kidney cancer treatment drugs @Drugs forAdvanced Kidney Cancer Treatment A snapshot of the Advanced Kidney Cancer Pipeline Drugs mentioned in the report: Learn more about the emerging...
Action plan for optimizing the design of clinical trials in chronic kidney diseasechronic kidney disease, clinical trial, clinical trial design, clinical trial endpointsThe goals of the GKHA are to: 1. Provide a high level overview of the current state of kidney care (chronic kidney disease [...
Recently completed clinical trials highlight the potential of new therapies for individuals with kidney disease. Below are the findings of two of these studies, which are being presented at ASN Kidney Week 2013 November 5-10 at the Georgia World Congress Center in Atlanta, GA. Kidney disease can...